Although the results obtained in the present study are in line with the previous reports on efficacy of EPA30 or gp100 vaccine40 in cytotoxic activity of CTL cells in melanoma, a significantly higher effect of the combination therapy group in liposomal form (i.e. Lip-EPA + Lip-gp100) was the new finding of our study. The gene discussed is PMEL; the disease is melanoma.